BACKGROUND: Pharmacovigilance and drug-safety surveillance are crucial for monitoring adverse drug events (ADEs), but the main ADE-reporting systems such as Food and Drug Administration Adverse Event Reporting System face challenges such as underreporting. Therefore, as complementary surveillance, data on ADEs are extracted from electronic health record (EHR) notes via natural language processing (NLP). As NLP develops, many up-to-date machine-learning techniques are introduced in this field, such as deep learning and multi-task learning (MTL). However, only a few studies have focused on employing such techniques to extract ADEs. OBJECTIVE: We aimed to design a deep learning model for extracting ADEs and related information such as medicati...
Background: Pharmacovigilance and safety reporting, which involves processes for monitoring the use ...
Background: Pharmacovigilance and safety reporting, which involves processes for monitoring the use ...
BACKGROUND: Knowledge about adverse drug reactions (ADRs) in the population is limited because of un...
INTRODUCTION: This work describes the Medication and Adverse Drug Events from Electronic Health Reco...
The Information Extraction from clinical notes provides relevant information to identify adverse sid...
BACKGROUND: Medication and adverse drug event (ADE) information extracted from electronic health rec...
Adverse drug events (ADEs) as a set of detriments caused by medications, have led to additional medi...
<p>Multiple data sources are preferred in adverse drug event (ADEs) surveillance owing to inadequaci...
<p>Multiple data sources are preferred in adverse drug event (ADEs) surveillance owing to inadequaci...
<p>Multiple data sources are preferred in adverse drug event (ADEs) surveillance owing to inadequaci...
<p>Multiple data sources are preferred in adverse drug event (ADEs) surveillance owing to inadequaci...
<p>Multiple data sources are preferred in adverse drug event (ADEs) surveillance owing to inadequaci...
BackgroundThe importance of identifying and evaluating adverse drug reactions (ADRs) has been widely...
The objective of this study was to determine whether the Food and Drug Administration’s Adverse Even...
BACKGROUND:The importance of identifying and evaluating adverse drug reactions (ADRs) has been widel...
Background: Pharmacovigilance and safety reporting, which involves processes for monitoring the use ...
Background: Pharmacovigilance and safety reporting, which involves processes for monitoring the use ...
BACKGROUND: Knowledge about adverse drug reactions (ADRs) in the population is limited because of un...
INTRODUCTION: This work describes the Medication and Adverse Drug Events from Electronic Health Reco...
The Information Extraction from clinical notes provides relevant information to identify adverse sid...
BACKGROUND: Medication and adverse drug event (ADE) information extracted from electronic health rec...
Adverse drug events (ADEs) as a set of detriments caused by medications, have led to additional medi...
<p>Multiple data sources are preferred in adverse drug event (ADEs) surveillance owing to inadequaci...
<p>Multiple data sources are preferred in adverse drug event (ADEs) surveillance owing to inadequaci...
<p>Multiple data sources are preferred in adverse drug event (ADEs) surveillance owing to inadequaci...
<p>Multiple data sources are preferred in adverse drug event (ADEs) surveillance owing to inadequaci...
<p>Multiple data sources are preferred in adverse drug event (ADEs) surveillance owing to inadequaci...
BackgroundThe importance of identifying and evaluating adverse drug reactions (ADRs) has been widely...
The objective of this study was to determine whether the Food and Drug Administration’s Adverse Even...
BACKGROUND:The importance of identifying and evaluating adverse drug reactions (ADRs) has been widel...
Background: Pharmacovigilance and safety reporting, which involves processes for monitoring the use ...
Background: Pharmacovigilance and safety reporting, which involves processes for monitoring the use ...
BACKGROUND: Knowledge about adverse drug reactions (ADRs) in the population is limited because of un...